Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10828 | 964 | 36.5 | 82% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STATIN MYOPATHY | Author keyword | 13 | 67% | 1% | 12 |
2 | STATIN INTOLERANCE | Author keyword | 9 | 50% | 1% | 13 |
3 | MYALGIA | Author keyword | 6 | 14% | 4% | 39 |
4 | SCRIPPS MERCY CLIN | Address | 6 | 100% | 0% | 4 |
5 | MUSCLE SYMPTOMS | Author keyword | 5 | 63% | 1% | 5 |
6 | STATIN ASSOCIATED MYOPATHY | Author keyword | 4 | 75% | 0% | 3 |
7 | STATIN INDUCED MYOPATHY | Author keyword | 4 | 56% | 1% | 5 |
8 | MUSCLE TOXICITY | Author keyword | 4 | 46% | 1% | 6 |
9 | STATIN SAFETY | Author keyword | 3 | 100% | 0% | 3 |
10 | HENRY LOW HEART | Address | 3 | 14% | 2% | 20 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STATIN MYOPATHY | 13 | 67% | 1% | 12 | Search STATIN+MYOPATHY | Search STATIN+MYOPATHY |
2 | STATIN INTOLERANCE | 9 | 50% | 1% | 13 | Search STATIN+INTOLERANCE | Search STATIN+INTOLERANCE |
3 | MYALGIA | 6 | 14% | 4% | 39 | Search MYALGIA | Search MYALGIA |
4 | MUSCLE SYMPTOMS | 5 | 63% | 1% | 5 | Search MUSCLE+SYMPTOMS | Search MUSCLE+SYMPTOMS |
5 | STATIN ASSOCIATED MYOPATHY | 4 | 75% | 0% | 3 | Search STATIN+ASSOCIATED+MYOPATHY | Search STATIN+ASSOCIATED+MYOPATHY |
6 | STATIN INDUCED MYOPATHY | 4 | 56% | 1% | 5 | Search STATIN+INDUCED+MYOPATHY | Search STATIN+INDUCED+MYOPATHY |
7 | MUSCLE TOXICITY | 4 | 46% | 1% | 6 | Search MUSCLE+TOXICITY | Search MUSCLE+TOXICITY |
8 | STATIN SAFETY | 3 | 100% | 0% | 3 | Search STATIN+SAFETY | Search STATIN+SAFETY |
9 | MUSCLE PAINS | 3 | 60% | 0% | 3 | Search MUSCLE+PAINS | Search MUSCLE+PAINS |
10 | MYOTOXICITY | 2 | 12% | 2% | 19 | Search MYOTOXICITY | Search MYOTOXICITY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPID LOWERING DRUGS | 31 | 26% | 11% | 102 |
2 | STATIN ASSOCIATED MYOPATHY | 21 | 41% | 4% | 39 |
3 | MYOSITIS MYALGIA | 18 | 83% | 1% | 10 |
4 | INDUCED DERMATOMYOSITIS | 15 | 88% | 1% | 7 |
5 | PRAVASTATIN GEMFIBROZIL THERAPY | 15 | 88% | 1% | 7 |
6 | INDUCED MYOPATHY | 13 | 26% | 4% | 41 |
7 | MEDIATED NECROTIZING MYOPATHY | 12 | 56% | 2% | 15 |
8 | INDUCED RHABDOMYOLYSIS | 12 | 35% | 3% | 27 |
9 | SERUM UBIQUINONE | 12 | 54% | 2% | 15 |
10 | CREATINE KINASE LEVELS | 11 | 40% | 2% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Narrative Review: Statin-Related Myopathy | 2009 | 140 | 72 | 57% |
Statin-induced myopathy: a review and update | 2011 | 72 | 83 | 58% |
Statin myotoxicity: A review of genetic susceptibility factors | 2014 | 27 | 127 | 46% |
New insights into mechanisms of statin-associated myotoxicity | 2008 | 67 | 36 | 86% |
Statin induced myotoxicity | 2012 | 33 | 78 | 65% |
Effect of Statins on Skeletal Muscle: Exercise, Myopathy, and Muscle Outcomes | 2012 | 24 | 30 | 77% |
Statins as a possible cause of inflammatory and necrotizing myopathies | 2012 | 20 | 30 | 77% |
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management | 2015 | 3 | 98 | 48% |
The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis | 2007 | 90 | 27 | 81% |
Statin induced myopathy | 2008 | 29 | 22 | 95% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SCRIPPS MERCY CLIN | 6 | 100% | 0.4% | 4 |
2 | HENRY LOW HEART | 3 | 14% | 2.1% | 20 |
3 | SLOVENIA INTERNAL MED | 1 | 100% | 0.2% | 2 |
4 | OFF HLTH PROMOT DIS PREVENT | 1 | 17% | 0.7% | 7 |
5 | INTERNAL MED ANGIOL ATHEROSCLEROSIS | 1 | 33% | 0.2% | 2 |
6 | BIOL SCI PHARMACEUT SCI | 1 | 50% | 0.1% | 1 |
7 | CIUDAD JAEN | 1 | 50% | 0.1% | 1 |
8 | DIABETES ENDOCRINOL METABOL | 1 | 50% | 0.1% | 1 |
9 | DIAG TREATMENT ATHEROSCLEROSIS LIPID DIS | 1 | 50% | 0.1% | 1 |
10 | DP BIOTECH | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000237990 | OATP1B1//SLCO1B1//OATP |
2 | 0.0000214910 | FENOVERINE//IDIOPATHIC HYPER CK EMIA//HYPERCKEMIA |
3 | 0.0000157119 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN |
4 | 0.0000143590 | PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN |
5 | 0.0000115623 | NK 104//PITAVASTATIN//CAS 147526 32 7 |
6 | 0.0000112298 | EZETIMIBE//CHOLESTEROL ABSORPTION INHIBITOR//COLESEVELAM |
7 | 0.0000090286 | FENOFIBRIC ACID//FENOFIBRATE//FIBRATES |
8 | 0.0000084209 | COENZYME Q10//UBIQUINONE//COENZYME Q |
9 | 0.0000083764 | P DIS TB INTERNAL MED//3 HYDROXY 3 METHYLGLUTARYL CO ENZYME A REDUCTASE INHIBITOR//INTER PROGRAM IMMUNOL |
10 | 0.0000083168 | LOVASTATIN//BB BIOCYT//PEDIAT PNEUMONOL ALLERG DIS HEMATOL |